Blood biomarkers and Ki-67 proliferation marker in breast cancer
Metastasis is the leading cause of death in patients with breast cancer (BC). It is known that the lesion of regional lymph nodes by tumor cells is more common in tumors with higher proliferative activity. Moreover, there is literature evidence on effects of cytokines and proteins upon the migration...
Saved in:
| Main Authors: | A. A. Studenikina, E. S. Mikhaylova, S. A. Arkhipov, N. A. Varaksin, A. V. Proskura, A. I. Autenshlyus |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists
2023-04-01
|
| Series: | Медицинская иммунология |
| Subjects: | |
| Online Access: | https://www.mimmun.ru/mimmun/article/view/2570 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
P63 and Ki-67 expression in radicular cyst
by: Mohammed Amjed Alsaegh, et al.
Published: (2023-09-01) -
CD34 and Ki-67 Immunoexpression in Periapical Granulomas: Implications for Angiogenesis and Cellular Proliferation
by: Ciprian Roi, et al.
Published: (2024-10-01) -
Metastatic prolactinoma: case report with immunohistochemical assessment for p53 and Ki-67 antigens Prolactinoma metastático: relato de caso com avaliação imuno-histoquímica para os antígenos p53 e Ki-67
by: Paulo S. Crusius, et al.
Published: (2005-09-01) -
Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
by: Zilan Luo, et al.
Published: (2025-12-01) -
Ki67 index importance in patients with breast cancer
by: O. Bondar
Published: (2024-12-01)